HEADER VIRAL PROTEIN 06-SEP-22 8AZP TITLE STRUCTURE OF SARS-COV-2 NSP3 MACRODOMAIN IN COMPLEX WITH BETA-METHYL- TITLE 2 ADP COMPND MOL_ID: 1; COMPND 2 MOLECULE: PAPAIN-LIKE PROTEASE NSP3; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: NON-STRUCTURAL PROTEIN 3,NSP3,PL2-PRO,PAPAIN-LIKE COMPND 5 PROTEINASE,PL-PRO; COMPND 6 EC: 3.4.19.12,3.4.22.-; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 3 2; SOURCE 4 ORGANISM_TAXID: 2697049; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: ROSETTA 2 KEYWDS SARS-COV-2, NSP3, MACRODOMAIN, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR S.SANDER,H.TIDOW,R.FLIEGERT,M.SANDMANN REVDAT 1 20-MAR-24 8AZP 0 JRNL AUTH S.SANDER,H.TIDOW,R.FLIEGERT,M.SANDMANN JRNL TITL STRUCTURE OF SARS-COV-2 NSP3 MACRODOMAIN IN COMPLEX WITH JRNL TITL 2 BETA-METHYL-ADP JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.35 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 3 NUMBER OF REFLECTIONS : 49013 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.190 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.880 REMARK 3 FREE R VALUE TEST SET COUNT : 2394 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 48.3500 - 4.1200 1.00 2980 149 0.1854 0.2029 REMARK 3 2 4.1100 - 3.2700 1.00 2836 153 0.1725 0.1857 REMARK 3 3 3.2600 - 2.8500 1.00 2811 140 0.1992 0.1890 REMARK 3 4 2.8500 - 2.5900 1.00 2768 145 0.1920 0.2148 REMARK 3 5 2.5900 - 2.4100 0.99 2795 141 0.1924 0.2325 REMARK 3 6 2.4100 - 2.2600 0.99 2729 153 0.1936 0.2148 REMARK 3 7 2.2600 - 2.1500 0.99 2730 129 0.1794 0.2205 REMARK 3 8 2.1500 - 2.0600 0.99 2752 145 0.1764 0.1928 REMARK 3 9 2.0600 - 1.9800 0.99 2695 150 0.1782 0.2138 REMARK 3 10 1.9800 - 1.9100 0.98 2721 129 0.1923 0.2439 REMARK 3 11 1.9100 - 1.8500 0.99 2709 144 0.2050 0.2733 REMARK 3 12 1.8500 - 1.8000 0.98 2676 149 0.2049 0.2104 REMARK 3 13 1.8000 - 1.7500 0.98 2714 116 0.2052 0.1935 REMARK 3 14 1.7500 - 1.7100 0.98 2701 127 0.2117 0.2203 REMARK 3 15 1.7100 - 1.6700 0.98 2646 154 0.2167 0.2769 REMARK 3 16 1.6700 - 1.6300 0.98 2679 149 0.2316 0.3240 REMARK 3 17 1.6300 - 1.6000 0.98 2677 121 0.2424 0.2652 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.158 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.800 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.62 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.54 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2712 REMARK 3 ANGLE : 0.978 3690 REMARK 3 CHIRALITY : 0.059 432 REMARK 3 PLANARITY : 0.005 466 REMARK 3 DIHEDRAL : 15.514 958 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8AZP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 07-SEP-22. REMARK 100 THE DEPOSITION ID IS D_1292125494. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-AUG-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PETRA III, EMBL C/O DESY REMARK 200 BEAMLINE : P13 (MX1) REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS VERSION JAN 10, 2022 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49126 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.600 REMARK 200 RESOLUTION RANGE LOW (A) : 48.350 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.6 REMARK 200 DATA REDUNDANCY : 13.20 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 17.0300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.66 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.170 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6WEN REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.40 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.8 M K2HPO4/NAH2PO4, PH 8.2, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.77150 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.41550 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.54700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 41.41550 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.77150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.54700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -3 REMARK 465 PRO A -2 REMARK 465 MET A -1 REMARK 465 ASP A 0 REMARK 465 GLY A 1 REMARK 465 GLU A 2 REMARK 465 LYS A 175 REMARK 465 GLY B -3 REMARK 465 PRO B -2 REMARK 465 MET B -1 REMARK 465 ASP B 0 REMARK 465 GLY B 1 REMARK 465 GLU B 2 REMARK 465 LYS B 175 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU A 120 O HOH A 301 1.99 REMARK 500 O HOH A 425 O HOH A 433 2.05 REMARK 500 O HOH B 422 O HOH B 455 2.07 REMARK 500 O HOH A 422 O HOH A 433 2.11 REMARK 500 OD1 ASP A 14 O HOH A 302 2.11 REMARK 500 O HOH A 422 O HOH A 451 2.13 REMARK 500 CE LYS A 110 O HOH A 370 2.14 REMARK 500 O HOH A 303 O HOH A 318 2.15 REMARK 500 O HOH A 404 O HOH A 454 2.17 REMARK 500 O HOH A 302 O HOH A 428 2.18 REMARK 500 O HOH A 421 O HOH A 456 2.18 REMARK 500 OG SER B 111 O HOH B 301 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 86 -131.57 57.32 REMARK 500 HIS B 86 -129.57 55.40 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8AZD RELATED DB: PDB REMARK 900 SAME PROTEIN, DIFFERENT LIGAND DBREF 8AZP A 2 175 UNP P0DTC1 R1A_SARS2 1024 1197 DBREF 8AZP B 2 175 UNP P0DTC1 R1A_SARS2 1024 1197 SEQADV 8AZP GLY A -3 UNP P0DTC1 EXPRESSION TAG SEQADV 8AZP PRO A -2 UNP P0DTC1 EXPRESSION TAG SEQADV 8AZP MET A -1 UNP P0DTC1 EXPRESSION TAG SEQADV 8AZP ASP A 0 UNP P0DTC1 EXPRESSION TAG SEQADV 8AZP GLY A 1 UNP P0DTC1 EXPRESSION TAG SEQADV 8AZP GLY B -3 UNP P0DTC1 EXPRESSION TAG SEQADV 8AZP PRO B -2 UNP P0DTC1 EXPRESSION TAG SEQADV 8AZP MET B -1 UNP P0DTC1 EXPRESSION TAG SEQADV 8AZP ASP B 0 UNP P0DTC1 EXPRESSION TAG SEQADV 8AZP GLY B 1 UNP P0DTC1 EXPRESSION TAG SEQRES 1 A 179 GLY PRO MET ASP GLY GLU VAL ASN SER PHE SER GLY TYR SEQRES 2 A 179 LEU LYS LEU THR ASP ASN VAL TYR ILE LYS ASN ALA ASP SEQRES 3 A 179 ILE VAL GLU GLU ALA LYS LYS VAL LYS PRO THR VAL VAL SEQRES 4 A 179 VAL ASN ALA ALA ASN VAL TYR LEU LYS HIS GLY GLY GLY SEQRES 5 A 179 VAL ALA GLY ALA LEU ASN LYS ALA THR ASN ASN ALA MET SEQRES 6 A 179 GLN VAL GLU SER ASP ASP TYR ILE ALA THR ASN GLY PRO SEQRES 7 A 179 LEU LYS VAL GLY GLY SER CYS VAL LEU SER GLY HIS ASN SEQRES 8 A 179 LEU ALA LYS HIS CYS LEU HIS VAL VAL GLY PRO ASN VAL SEQRES 9 A 179 ASN LYS GLY GLU ASP ILE GLN LEU LEU LYS SER ALA TYR SEQRES 10 A 179 GLU ASN PHE ASN GLN HIS GLU VAL LEU LEU ALA PRO LEU SEQRES 11 A 179 LEU SER ALA GLY ILE PHE GLY ALA ASP PRO ILE HIS SER SEQRES 12 A 179 LEU ARG VAL CYS VAL ASP THR VAL ARG THR ASN VAL TYR SEQRES 13 A 179 LEU ALA VAL PHE ASP LYS ASN LEU TYR ASP LYS LEU VAL SEQRES 14 A 179 SER SER PHE LEU GLU MET LYS SER GLU LYS SEQRES 1 B 179 GLY PRO MET ASP GLY GLU VAL ASN SER PHE SER GLY TYR SEQRES 2 B 179 LEU LYS LEU THR ASP ASN VAL TYR ILE LYS ASN ALA ASP SEQRES 3 B 179 ILE VAL GLU GLU ALA LYS LYS VAL LYS PRO THR VAL VAL SEQRES 4 B 179 VAL ASN ALA ALA ASN VAL TYR LEU LYS HIS GLY GLY GLY SEQRES 5 B 179 VAL ALA GLY ALA LEU ASN LYS ALA THR ASN ASN ALA MET SEQRES 6 B 179 GLN VAL GLU SER ASP ASP TYR ILE ALA THR ASN GLY PRO SEQRES 7 B 179 LEU LYS VAL GLY GLY SER CYS VAL LEU SER GLY HIS ASN SEQRES 8 B 179 LEU ALA LYS HIS CYS LEU HIS VAL VAL GLY PRO ASN VAL SEQRES 9 B 179 ASN LYS GLY GLU ASP ILE GLN LEU LEU LYS SER ALA TYR SEQRES 10 B 179 GLU ASN PHE ASN GLN HIS GLU VAL LEU LEU ALA PRO LEU SEQRES 11 B 179 LEU SER ALA GLY ILE PHE GLY ALA ASP PRO ILE HIS SER SEQRES 12 B 179 LEU ARG VAL CYS VAL ASP THR VAL ARG THR ASN VAL TYR SEQRES 13 B 179 LEU ALA VAL PHE ASP LYS ASN LEU TYR ASP LYS LEU VAL SEQRES 14 B 179 SER SER PHE LEU GLU MET LYS SER GLU LYS HET OH9 A 201 28 HET OH9 B 201 28 HETNAM OH9 BETA-METHYL-ADENOSINE DIPHOSPHATE HETSYN OH9 [[(2~{R},3~{S},4~{R},5~{R})-5-(6-AMINOPURIN-9-YL)-3,4- HETSYN 2 OH9 BIS(OXIDANYL)OXOLAN-2-YL]METHOXY-OXIDANYL-PHOSPHORYL] HETSYN 3 OH9 METHYL HYDROGEN PHOSPHATE; [[(2R,3S,4R,5R)-5-(6- HETSYN 4 OH9 AMINOPURIN-9-YL)-3,4-BIS(OXIDANYL)OXOLAN-2-YL]METHOXY- HETSYN 5 OH9 OXIDANYL-PHOSPHORYL] METHYL HYDROGEN PHOSPHATE; BETA- HETSYN 6 OH9 METHYL-ADP FORMUL 3 OH9 2(C11 H17 N5 O10 P2) FORMUL 5 HOH *335(H2 O) HELIX 1 AA1 ASP A 22 LYS A 31 1 10 HELIX 2 AA2 GLY A 47 THR A 57 1 11 HELIX 3 AA3 ASN A 59 GLY A 73 1 15 HELIX 4 AA4 ASN A 99 GLY A 103 5 5 HELIX 5 AA5 GLN A 107 ASN A 115 1 9 HELIX 6 AA6 PHE A 116 HIS A 119 5 4 HELIX 7 AA7 ASP A 135 VAL A 147 1 13 HELIX 8 AA8 ASP A 157 GLU A 174 1 18 HELIX 9 AA9 ASP B 22 LYS B 31 1 10 HELIX 10 AB1 GLY B 47 THR B 57 1 11 HELIX 11 AB2 ASN B 59 GLY B 73 1 15 HELIX 12 AB3 ASN B 99 GLY B 103 5 5 HELIX 13 AB4 GLN B 107 ASN B 115 1 9 HELIX 14 AB5 PHE B 116 HIS B 119 5 4 HELIX 15 AB6 ASP B 135 VAL B 147 1 13 HELIX 16 AB7 ASP B 157 GLU B 174 1 18 SHEET 1 AA1 4 LEU A 10 LYS A 11 0 SHEET 2 AA1 4 VAL A 16 ASN A 20 -1 O ILE A 18 N LEU A 10 SHEET 3 AA1 4 ASN A 150 VAL A 155 1 O LEU A 153 N TYR A 17 SHEET 4 AA1 4 VAL A 121 ALA A 124 1 N LEU A 122 O TYR A 152 SHEET 1 AA2 3 VAL A 34 ALA A 38 0 SHEET 2 AA2 3 HIS A 91 VAL A 95 1 O LEU A 93 N ASN A 37 SHEET 3 AA2 3 SER A 80 SER A 84 -1 N LEU A 83 O CYS A 92 SHEET 1 AA3 4 LEU B 10 LYS B 11 0 SHEET 2 AA3 4 VAL B 16 ASN B 20 -1 O ILE B 18 N LEU B 10 SHEET 3 AA3 4 ASN B 150 VAL B 155 1 O LEU B 153 N TYR B 17 SHEET 4 AA3 4 VAL B 121 ALA B 124 1 N LEU B 122 O TYR B 152 SHEET 1 AA4 3 VAL B 34 ALA B 39 0 SHEET 2 AA4 3 HIS B 91 VAL B 96 1 O VAL B 95 N ALA B 39 SHEET 3 AA4 3 SER B 80 SER B 84 -1 N LEU B 83 O CYS B 92 CRYST1 59.543 75.094 82.831 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016795 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013317 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012073 0.00000